HKPD
Cellyan Biotechnology
$0.42
+$0.05 (+13.97%)Jul 27, 2026
Key metrics
The numbers that frame HKPD today
- Market cap
- $4.58M
- P/E (TTM)
- -6.5
- EV / FCF
- -13.5
- Gross margin
- 8.8%
- EV / Sales
- 0.4
- ROIC
- -7.7%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $0.31
- 52wk High
- $2.58
Growth
Revenue and earnings trend for HKPD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HKPD
Is Cellyan Biotechnology a good buy?
No. Cellyan Biotechnology has weak quality and poor momentum. Both signals point to a weaker setup. We think Cellyan Biotechnology is selling at a high price.
What is the market capitalization of HKPD?
Cellyan Biotechnology's market capitalization is $4.58M.
What is the P/E ratio for HKPD stock?
Cellyan Biotechnology's current P/E ratio is -6.5.
What is the 52-week high for HKPD stock?
The 52-week high for Cellyan Biotechnology is $2.58. The current close of $0.42 is 83.9% below that high.
What is the 52-week low for HKPD stock?
The 52-week low for Cellyan Biotechnology is $0.31. The current close of $0.42 is 34.2% above that low.
Does HKPD stock pay dividends?
Cellyan Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HKPD?
Cellyan Biotechnology's Debt / Equity ratio is 0.44.